Hostname: page-component-6766d58669-76mfw Total loading time: 0 Render date: 2026-05-14T12:52:11.738Z Has data issue: false hasContentIssue false

Toxoplasma gondii seroprevalence in wild boars (Sus scrofa) in Sweden and evaluation of ELISA test performance

Published online by Cambridge University Press:  06 November 2014

C. WALLANDER*
Affiliation:
Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden
J. FRÖSSLING
Affiliation:
Department of Disease Control and Epidemiology, National Veterinary Institute, Uppsala, Sweden Department of Animal Environment and Health, Swedish University of Agricultural Sciences, Skara, Sweden
I. VÅGSHOLM
Affiliation:
Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden
A. UGGLA
Affiliation:
Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden
A. LUNDÉN
Affiliation:
Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden Department of Virology, Immunobiology and Parasitology, National Veterinary Institute, Uppsala, Sweden
*
* Author for correspondence: Ms. C. Wallander, Swedish University of Agricultural Sciences, Department of Biomedical Sciences and Veterinary Public Health, Box 7036, 750 07 Uppsala, Sweden. (Email: camilla.gustafsson@slu.se)
Rights & Permissions [Opens in a new window]

Summary

Toxoplasma gondii is a zoonotic protozoan parasite, infecting a wide range of warm-blooded animals. The Swedish wild boar population is expanding and increased hunting provides its meat to a growing group of consumers. We performed a spatio-temporal investigation of T. gondii seroprevalence in Swedish wild boars. An ELISA was set up and evaluated against a commercial direct agglutination test, using Bayesian latent class analysis. The ELISA sensitivity and specificity were estimated to 79% and 85%, respectively. Of 1327 serum samples, 50% were positive. Thirty-four per cent of young wild boars and 55% of adults were positive (P < 0·001). The total seroprevalence ranged from 72% in 2005 to 38% in 2011 (P < 0·001), suggesting a declining trend. The highest seroprevalence, 65%, was recorded in South Sweden. In other regions it varied from 29% in Stockholm to 46% in East Middle Sweden.

Information

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Cambridge University Press 2014
Figure 0

Fig. 1. Geographical distribution of hunted wild boars in Sweden during the hunting seasons of 2009/2010 and 2010/2011. Based on data provided by the Swedish Association for Hunting and Wildlife Management, Wildlife Monitoring [9]. Colour scale represents number of animals hunted in each county (white areas represent no wild boars hunted). Regions (Nomenclature of Territorial Units for Statistics level 2) are drawn with black borders and black numbers on the map indicate percentage difference between proportion of hunted animals and proportion of sampled animals in each region. For example, South Sweden is underrepresented in our sample compared to the proportion of wild boars hunted in this region.

Figure 1

Table 1. Number and distribution of serum samples per year, age group (in months) and region

Figure 2

Fig. 2. Apparent seroprevalence (with 95% confidence intervals) in animals aged ⩽12 months and >12 months in 2010–2012.

Figure 3

Fig. 3. Apparent seroprevalence (with 95% confidence intervals) in different years.

Figure 4

Fig. 4. Apparent seroprevalence (with 95% confidence intervals) in different regions (Nomenclature of Territorial Units for Statistics level 2).

Figure 5

Fig. 5. Estimated (a) specificity and (b) sensitivity (including 95% credibility interval) of the in-house ELISA at different cut-offs, based on the latent class analysis.

Figure 6

Table 2. Cross-classified test results from the in-house ELISA (cut-off 0·39) and the DAT on the 242 samples included in the latent class analysis

Figure 7

Table 3. Results of latent class sensitivity analysis, showing mean posterior estimate (95% credible interval) for all estimated parameters, when analysed using priors for DAT (SeDAT/SpDAT), prevalences (π1/π2) and both